Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:Fexofenadine hydrochloride
go back to main search page
Accession:CHEBI:5051 term browser browse the term
Synonyms:related_synonym: Allegra (TN);   Formula=C32H39NO4.HCl;   Formula=C32H40ClNO4;   InChI=1S/C32H39NO4.ClH/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27;/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36);1H;   InChIKey=RRJFVPUCXDGFJB-UHFFFAOYSA-N;   SMILES=C1=CC=CC(=C1)C(C=2C=CC=CC2)(C3CCN(CC3)CCCC(C4=CC=C(C=C4)C(C(O)=O)(C)C)O)O.Cl
 xref: CAS:138452-21-8;   CAS:153439-40-8;   KEGG:D00671
 xref_mesh: MESH:C093230



show annotations for term's descendants           Sort by:
Fexofenadine hydrochloride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases expression
ISO
EXP
Adenosine Triphosphate promotes the reaction [ABCB11 protein results in increased uptake of fexofenadine]
fexofenadine results in decreased expression of ABCB11 mRNA
CTD PMID:18245269 PMID:24852568 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A affects response to substance
multiple interactions
affects export
ISO ABCB1 gene SNP affects the susceptibility to fexofenadine
Itraconazole promotes the reaction [ABCB1 gene SNP affects the susceptibility to fexofenadine]; Plant Extracts promotes the reaction [ABCB1 protein results in increased transport of fexofenadine]
ABCB1A protein affects the export of fexofenadine
CTD PMID:12545142 PMID:15536457 PMID:15821041 PMID:16084853 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions
increases export
ISO [SLCO1B1 protein co-treated with ABCC2 protein] results in increased uptake of fexofenadine; [SLCO1B3 protein co-treated with ABCC2 protein] results in increased uptake of fexofenadine
ABCC2 protein results in increased export of fexofenadine
CTD PMID:18180276 PMID:18245269 NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 affects transport
multiple interactions
ISO ABCC3 protein affects the transport of fexofenadine
Adenosine Triphosphate promotes the reaction [ABCC3 protein affects the transport of fexofenadine]
CTD PMID:18245269 NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
JBrowse link
G Apoe apolipoprotein E multiple interactions
decreases expression
ISO [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in decreased expression of CKM protein; [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in decreased expression of IL1A protein; [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased abundance of Cholesterol, LDL; [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of CCL3 protein; [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of NOS2 mRNA; [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of NOS3 mRNA; APOE gene mutant form inhibits the reaction [fexofenadine results in decreased expression of MLXIPL mRNA]; APOE protein results in decreased susceptibility to [Dietary Fats co-treated with fexofenadine]
fexofenadine results in decreased expression of APOE mRNA
CTD PMID:24852568 PMID:25020133 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL11 mRNA]; fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL11 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of CCL11 protein] CTD PMID:15460210 NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
JBrowse link
G Ccl17 C-C motif chemokine ligand 17 decreases expression ISO fexofenadine results in decreased expression of CCL17 mRNA; fexofenadine results in decreased expression of CCL17 protein CTD PMID:21109747 NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
JBrowse link
G Ccl22 C-C motif chemokine ligand 22 decreases expression ISO fexofenadine results in decreased expression of CCL22 mRNA; fexofenadine results in decreased expression of CCL22 protein CTD PMID:21109747 NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of CCL3 protein CTD PMID:25020133 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA]; fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] CTD PMID:15460210 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
JBrowse link
G Ckm creatine kinase, M-type multiple interactions ISO [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in decreased expression of CKM protein CTD PMID:25020133 NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
JBrowse link
G Ereg epiregulin decreases expression ISO fexofenadine results in decreased expression of EREG mRNA CTD PMID:32816093 NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
JBrowse link
G Gusb glucuronidase, beta multiple interactions ISO fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of GUSB protein]; fexofenadine inhibits the reaction [Histamine results in increased expression of GUSB protein] CTD PMID:11238657 NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
JBrowse link
G Hrh1 histamine receptor H 1 multiple interactions ISO fexofenadine binds to and results in decreased activity of HRH1 protein; fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased abundance of Calcium]; fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of GUSB protein] CTD PMID:11238657 PMID:19652466 NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression ISO fexofenadine results in decreased expression of ICAM1 protein CTD PMID:16270723 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G Il1a interleukin 1 alpha multiple interactions
decreases expression
ISO [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in decreased expression of IL1A protein
fexofenadine results in decreased expression of IL1A mRNA
CTD PMID:25020133 PMID:32816093 NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
JBrowse link
G Il1b interleukin 1 beta decreases expression ISO fexofenadine results in decreased expression of IL1B mRNA CTD PMID:32816093 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il6 interleukin 6 multiple interactions ISO fexofenadine inhibits the reaction [Histamine results in increased expression of IL6 protein] CTD PMID:11238657 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions
increases activity
ISO E 4031 inhibits the reaction [fexofenadine results in increased activity of KCNH2 protein mutant form]; fexofenadine inhibits the reaction [arsenic trioxide results in increased degradation of KCNH2 protein] CTD PMID:12070109 PMID:28521025 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
JBrowse link
G Mapk1 mitogen activated protein kinase 1 decreases phosphorylation ISO fexofenadine results in decreased phosphorylation of MAPK1 mRNA CTD PMID:21109747 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk3 mitogen activated protein kinase 3 decreases phosphorylation ISO fexofenadine results in decreased phosphorylation of MAPK3 mRNA CTD PMID:21109747 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression ISO fexofenadine results in decreased expression of MET mRNA CTD PMID:32816093 NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
JBrowse link
G Mlxipl MLX interacting protein-like multiple interactions
decreases expression
ISO APOE gene mutant form inhibits the reaction [fexofenadine results in decreased expression of MLXIPL mRNA] CTD PMID:24852568 NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO fexofenadine inhibits the reaction [TNF protein results in increased activity of MMP2 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP2 mRNA]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP2 protein] CTD PMID:15663564 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions ISO fexofenadine inhibits the reaction [TNF protein results in increased activity of MMP9 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 protein] CTD PMID:15663564 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO fexofenadine inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] CTD PMID:15663564 NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
decreases expression
ISO [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of NOS2 mRNA; fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
fexofenadine results in decreased expression of NOS2 mRNA
CTD PMID:17910814 PMID:25020133 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions ISO [fexofenadine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in increased expression of NOS3 mRNA CTD PMID:25020133 NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO [fexofenadine co-treated with Rifampin] results in increased activity of NR1I2 protein CTD PMID:20869355 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Pid1 phosphotyrosine interaction domain containing 1 increases expression ISO fexofenadine results in increased expression of PID1 mRNA CTD PMID:32816093 NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO fexofenadine results in decreased expression of PTGS2 mRNA CTD PMID:32816093 NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO fexofenadine inhibits the reaction [TNF protein results in increased activity of RELA protein] CTD PMID:15663564 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
JBrowse link
G Slc7a11 solute carrier family 7 member 11 decreases expression ISO fexofenadine results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 increases expression
increases uptake
multiple interactions
ISO fexofenadine results in increased expression of SLCO1B2 mRNA
SLCO1B3 protein results in increased uptake of fexofenadine
[SLCO1B3 protein co-treated with ABCC2 protein] results in increased uptake of fexofenadine; Cyclosporine inhibits the reaction [SLCO1B3 protein results in increased uptake of fexofenadine]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of fexofenadine]
CTD PMID:18180276 PMID:18245269 PMID:24852568 NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression ISO fexofenadine results in increased expression of SLPI mRNA CTD PMID:32816093 NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions ISO fexofenadine inhibits the reaction [TNF protein results in increased expression of TIMP1 protein] CTD PMID:15663564 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:1,212,972...1,217,664
JBrowse link
G Timp2 TIMP metallopeptidase inhibitor 2 multiple interactions ISO fexofenadine inhibits the reaction [TNF protein results in increased expression of TIMP2 protein] CTD PMID:15663564 NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO fexofenadine inhibits the reaction [TNF protein results in increased activity of MMP2 protein]; fexofenadine inhibits the reaction [TNF protein results in increased activity of MMP9 protein]; fexofenadine inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; fexofenadine inhibits the reaction [TNF protein results in increased activity of RELA protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of CCL11 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP2 mRNA]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP2 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of TIMP1 protein]; fexofenadine inhibits the reaction [TNF protein results in increased expression of TIMP2 protein] CTD PMID:15460210 PMID:15663564 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19911
    chemical entity 19909
      group 19863
        polyatomic entity 19862
          molecule 19752
            cyclic compound 19523
              organic cyclic compound 19526
                organic aromatic compound 19390
                  diarylmethane 9440
                    Fexofenadine hydrochloride 38
Path 2
Term Annotations click to browse term
  CHEBI ontology 19911
    subatomic particle 19909
      composite particle 19909
        hadron 19880
          baryon 19880
            nucleon 19909
              atomic nucleus 19880
                atom 19909
                  main group element atom 19849
                    p-block element atom 19849
                      p-block molecular entity 19826
                        carbon group molecular entity 19766
                          organic molecular entity 19785
                            organic molecule 19737
                              organic cyclic compound 19526
                                organic aromatic compound 19390
                                  diarylmethane 9440
                                    Fexofenadine hydrochloride 38
paths to the root